Biosplice Therapeutics
American biopharmaceutical company
From Wikipedia, the free encyclopedia
Biosplice Therapeutics, Inc. (formerly Samumed, LLC) is a private biopharmaceutical company based in San Diego, California.[1] It was founded in 2008 by Osman Kibar.[2]
Company typePrivately held company
IndustryRegenerative medicine
Founded2008 in San Diego, USA
FounderOsman Kibar
| Company type | Privately held company |
|---|---|
| Industry | Regenerative medicine |
| Founded | 2008 in San Diego, USA |
| Founder | Osman Kibar |
| Fate | renamed from Samumed |
| Headquarters | San Diego, USA |
| Website | www |
Samumed's products in development target novel components of the Wnt signaling pathway.[3][4][5] The company focuses on potential treatments for several diseases; its osteoarthritis program is its most advanced.[4][6]
